Xiaoliang L. Xu

1.4k total citations
29 papers, 1.1k citations indexed

About

Xiaoliang L. Xu is a scholar working on Oncology, Molecular Biology and Ophthalmology. According to data from OpenAlex, Xiaoliang L. Xu has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Ophthalmology. Recurrent topics in Xiaoliang L. Xu's work include Cancer-related Molecular Pathways (9 papers), Ocular Oncology and Treatments (8 papers) and Ubiquitin and proteasome pathways (4 papers). Xiaoliang L. Xu is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Ocular Oncology and Treatments (8 papers) and Ubiquitin and proteasome pathways (4 papers). Xiaoliang L. Xu collaborates with scholars based in China, United States and Japan. Xiaoliang L. Xu's co-authors include Xiao‐Qin Liu, Lin‐Bing Sun, David Cobrinik, David H. Abramson, Suresh C. Jhanwar, Aihong Liu, Hardeep Singh, Lu Wang, Yuqiang Fang and Douglas Forrest and has published in prestigious journals such as Nature, Cell and Nature Genetics.

In The Last Decade

Xiaoliang L. Xu

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoliang L. Xu China 16 373 336 302 257 192 29 1.1k
Li Su China 25 895 2.4× 394 1.2× 39 0.1× 63 0.2× 184 1.0× 82 2.0k
Chengbao Liu China 28 551 1.5× 467 1.4× 13 0.0× 80 0.3× 727 3.8× 79 2.1k
Ruifen Wang China 20 216 0.6× 215 0.6× 12 0.0× 84 0.3× 493 2.6× 76 1.1k
Rupeng Zhang China 28 493 1.3× 251 0.7× 12 0.0× 58 0.2× 389 2.0× 99 2.2k
Liwei Zhu China 16 123 0.3× 63 0.2× 57 0.2× 20 0.1× 172 0.9× 45 777
Bingqian Liu China 18 161 0.4× 43 0.1× 227 0.8× 16 0.1× 297 1.5× 43 1.0k
Ran Sun China 30 1.1k 2.8× 393 1.2× 15 0.0× 28 0.1× 394 2.1× 109 2.4k
Seung‐Hoon Kim South Korea 14 239 0.6× 119 0.4× 18 0.1× 76 0.3× 464 2.4× 33 1.4k

Countries citing papers authored by Xiaoliang L. Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaoliang L. Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoliang L. Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoliang L. Xu more than expected).

Fields of papers citing papers by Xiaoliang L. Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoliang L. Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoliang L. Xu. The network helps show where Xiaoliang L. Xu may publish in the future.

Co-authorship network of co-authors of Xiaoliang L. Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoliang L. Xu. A scholar is included among the top collaborators of Xiaoliang L. Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoliang L. Xu. Xiaoliang L. Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhaohui, Zhihui Bai, Weijie Mao, & Xiaoliang L. Xu. (2025). Transferable layered physics-informed learning for status sensing of high-power induction furnace. ISA Transactions.
2.
Zhang, Zhaohui, et al.. (2024). A meta-PINN framework for online operational monitoring of high-power induction furnace. Journal of Manufacturing Systems. 76. 11–24. 4 indexed citations
3.
Elahi, Abul, Xiaoliang L. Xu, Alexia Eliades, et al.. (2023). Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects. Advances in Biological Regulation. 88. 100964–100964. 1 indexed citations
4.
Zhang, Tao, Xiaoliang L. Xu, Zhifeng Zhang, et al.. (2023). Three-Dimensional Macroporous rGO-Aerogel-Based Composite Phase-Change Materials with High Thermal Storage Capacity and Enhanced Thermal Conductivity. Materials. 16(13). 4878–4878. 7 indexed citations
5.
Jhanwar, Suresh C., Xiaoliang L. Xu, Abul Elahi, & David H. Abramson. (2020). Cancer genomics of lung cancer including malignant mesothelioma: A brief overview of current status and future prospects. Advances in Biological Regulation. 78. 100723–100723. 6 indexed citations
6.
Xu, Xiaoliang L., et al.. (2017). Genomic instability and proliferation/survival pathways in RB1-deficient malignancies. Advances in Biological Regulation. 64. 20–32. 15 indexed citations
7.
Hoseini, Sayed Shahabuddin, Konstantin Dobrenkov, Dmitry Pankov, Xiaoliang L. Xu, & Nai‐Kong V. Cheung. (2017). Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2. OncoImmunology. 6(6). e1320625–e1320625. 31 indexed citations
8.
Pan, Hui, Renbing Jia, Leilei Zhang, et al.. (2015). BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells. The International Journal of Biochemistry & Cell Biology. 60. 176–184. 43 indexed citations
9.
Chen, Yingwen, et al.. (2015). A novel chemical/biological combined technique for N, N-dimethylformamide wastewater treatment. Environmental Technology. 37(9). 1088–1093. 25 indexed citations
10.
Xu, Xiaoliang L., Timothy Cardozo, Dan‐Ning Hu, et al.. (2014). Pharmacologic Targeting of Skp2 in Retinoblastoma. Investigative Ophthalmology & Visual Science. 55(13). 850–850. 1 indexed citations
11.
Francis, Jasmine H., Xiaoliang L. Xu, Y. Pierre Gobin, et al.. (2014). Death by Water: Precautionary Water Submersion for Intravitreal Injection of Retinoblastoma Eyes. The Open Ophthalmology Journal. 8(1). 7–11. 16 indexed citations
12.
Xu, Xiaoliang L., Hardeep Singh, Lu Wang, et al.. (2014). Rb suppresses human cone-precursor-derived retinoblastoma tumours. Nature. 514(7522). 385–388. 165 indexed citations
13.
Yan, Xiaokang, Qiong Huang, Bing Li, et al.. (2012). Catalytic performance of LaCo0.5M0.5O3 (M=Mn, Cr, Fe, Ni, Cu) perovskite-type oxides and LaCo0.5Mn0.5O3 supported on cordierite for CO oxidation. Journal of Industrial and Engineering Chemistry. 19(2). 561–565. 49 indexed citations
14.
Xu, Xiaoliang L., Thomas C. M. Lee, Christine Cheng, et al.. (2010). Tumor-Associated Retinal Astrocytes Promote Retinoblastoma Cell Proliferation Through Production of IGFBP-5. American Journal Of Pathology. 177(1). 424–435. 33 indexed citations
15.
Xu, Xiaoliang L., Yuqiang Fang, Thomas C. Lee, et al.. (2009). Retinoblastoma Has Properties of a Cone Precursor Tumor and Depends Upon Cone-Specific MDM2 Signaling. Cell. 137(6). 1018–1031. 175 indexed citations
16.
Wang, Hongbo, Frederick Bauzon, Peng Ji, et al.. (2009). Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/− mice. Nature Genetics. 42(1). 83–88. 96 indexed citations
17.
Xu, Xiaoliang L., et al.. (2009). Adsorption separation of carbon dioxide, methane and nitrogen on monoethanol amine modified β-zeolite. Journal of Natural Gas Chemistry. 18(2). 167–172. 120 indexed citations
18.
Tang, Tingting, et al.. (2005). Ectopic bone formation of human bone morphogenetic protein-2 gene transfected goat bone marrow-derived mesenchymal stem cells in nude mice.. PubMed. 8(1). 3–7. 15 indexed citations
19.
Miao, Xinyu, et al.. (2004). Structure, X-ray photoelectron spectroscopy and photoluminescence properties of highly ordered ZnO microrods. Optical Materials. 27(10). 1602–1605. 47 indexed citations
20.
Xu, Xiaoliang L., et al.. (2003). [Preparation of a biphasic calcined bone of beta-TCP/HAP and its application in BMP-2 gene medicine].. PubMed. 20(4). 630–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026